DSE

dermatan sulfate epimerase

Basic information

Region (hg38): 6:116254173-116444861

Previous symbols: [ "SART2" ]

Links

ENSG00000111817NCBI:29940OMIM:605942HGNC:21144Uniprot:Q9UL01AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Ehlers-Danlos syndrome, musculocontractural type 2 (Limited), mode of inheritance: AR
  • Ehlers-Danlos syndrome, musculocontractural type 2 (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, musculocontractural type 2 (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, musculocontractural type 2 (Moderate), mode of inheritance: AR
  • Ehlers-Danlos syndrome, musculocontractural type 2 (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, musculocontractural type (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ehlers-Danlos syndrome, musculocontractural type 2ARCardiovascular; Hematologic; MusculoskeletalExtrapolating from similar types of Ehlers-Danlos syndrome, clinical issues relate to connective tissue fragility may affect multiple organs related to bleeding diatheses (eg, after minor trauma), such that recognition may allow precautions and preventive measures, as well as rapid treatmentCardiovascular; Craniofacial; Dental; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Ophthalmologic23704329

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DSE gene.

  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DSE gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
101
clinvar
2
clinvar
103
missense
155
clinvar
5
clinvar
6
clinvar
166
nonsense
2
clinvar
3
clinvar
5
start loss
0
frameshift
1
clinvar
2
clinvar
5
clinvar
8
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
2
clinvar
27
clinvar
38
clinvar
20
clinvar
87
Total 1 7 190 144 29

Variants in DSE

This is a list of pathogenic ClinVar variants found in the DSE region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-116278562-C-T Likely benign (Jun 08, 2018)745845
6-116278567-G-A Likely benign (Oct 13, 2022)2416621
6-116278696-T-C not specified Benign (Jan 04, 2024)773200
6-116278715-G-A Likely benign (Jul 22, 2021)1573308
6-116278733-G-T not specified • TSPYL1-related disorder Likely benign (Dec 20, 2023)718447
6-116278748-A-G TSPYL1-related disorder Likely benign (Jul 12, 2019)3050285
6-116278764-A-G Inborn genetic diseases Uncertain significance (Apr 09, 2024)2052939
6-116278772-A-G Likely benign (Sep 03, 2021)1542141
6-116278911-A-G Sudden infant death-dysgenesis of the testes syndrome Uncertain significance (-)1339090
6-116278928-T-C Likely benign (Dec 19, 2022)2959962
6-116278942-C-A Inborn genetic diseases Uncertain significance (Oct 04, 2022)2316335
6-116278948-C-T Inborn genetic diseases Uncertain significance (Jul 06, 2021)2390629
6-116279003-C-T Likely benign (Nov 01, 2022)3023174
6-116279076-T-C Inborn genetic diseases Uncertain significance (Jan 16, 2024)3183876
6-116279104-TCA-T Sudden infant death-dysgenesis of the testes syndrome Pathogenic/Likely pathogenic (Sep 22, 2024)805870
6-116279184-T-G Inborn genetic diseases Uncertain significance (Sep 23, 2023)3183875
6-116279191-C-A Inborn genetic diseases Uncertain significance (Nov 04, 2022)2321713
6-116279212-C-T Inborn genetic diseases Uncertain significance (Jan 09, 2024)3183874
6-116279230-C-T Inborn genetic diseases Uncertain significance (Jul 19, 2022)2375233
6-116279246-C-A Inborn genetic diseases Uncertain significance (Apr 08, 2022)2282604
6-116279251-C-A Uncertain significance (Aug 24, 2022)2026869
6-116279256-ACCT-A Likely benign (Apr 03, 2023)2063485
6-116279265-T-G Inborn genetic diseases Uncertain significance (Jun 11, 2021)2232478
6-116279290-C-T Benign (Jan 29, 2024)1601556
6-116279302-T-TCAC Ehlers-Danlos syndrome, musculocontractural type 2 Benign (Jan 31, 2024)1301648

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DSEprotein_codingprotein_codingENST00000331677 5187089
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6330.3671257330151257480.0000596
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.033935230.7510.00002726327
Missense in Polyphen111194.650.570262379
Synonymous1.081812010.9030.00001101853
Loss of Function4.54838.30.2090.00000206422

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005790.0000579
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001320.000105
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts D-glucuronic acid to L-iduronic acid (IdoUA) residues. {ECO:0000269|PubMed:16505484}.;
Pathway
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Dermatan sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;dermatan sulfate biosynthesis (late stages);Proteoglycan biosynthesis;dermatan sulfate biosynthesis;Metabolism (Consensus)

Recessive Scores

pRec
0.150

Intolerance Scores

loftool
0.761
rvis_EVS
-0.35
rvis_percentile_EVS
29.54

Haploinsufficiency Scores

pHI
0.168
hipred
Y
hipred_score
0.554
ghis
0.543

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.841

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dse
Phenotype
growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); limbs/digits/tail phenotype; reproductive system phenotype;

Gene ontology

Biological process
heparan sulfate proteoglycan biosynthetic process;chondroitin sulfate biosynthetic process;dermatan sulfate biosynthetic process
Cellular component
Golgi membrane;nucleoplasm;endoplasmic reticulum;Golgi apparatus;cytosol;integral component of membrane
Molecular function
chondroitin-glucuronate 5-epimerase activity